Search
for
Sort by
Research 391–420 of 1000+
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- USE OF TOFACITINIB IN DIFFICULT TO TREAT CLINICALLY AMYOPATHIC DERMATOMYOSITIS
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- Janus kinase inhibitors for alopecia areata: A narrative review
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Alopecia areata
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- Janus kinase inhibitor as a therapeutic option in alopecia areata. Case report
- Alopecia Areata, triggered by psychological stress and successfully treated with a Janus kinase inhibitor. Case report
- Inhibidor janus kinasa como opción terapéutica en alopecia areata. Reporte de caso
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
- 0350 Impact of switching janus kinase inhibitors in the treatment of severe alopecia areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- A novel therapeutic paradigm for patients with extensive alopecia areata